Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

r of 2011. Gross margin as a percent of total revenue was 78.2 percent, reflecting a decrease of 4.3 percentage points compared with the third quarter of 2010. The decrease in gross margin percent was due primarily to the impact of foreign exchange rates on inventories sold during the quarter.

Total operating expense, defined as the sum of research and development, marketing, selling and administrative expenses, increased 10 percent compared with the third quarter of 2010. Marketing, selling and administrative expenses increased 13 percent to $1.918 billion. Research and development expenses increased 5 percent to $1.281 billion, or 20.8 percent of total revenue. Total operating expense growth was driven by the recently-announced diabetes collaboration with Boehringer Ingelheim, including late-stage clinical trial costs, as well as the effect of foreign exchange rates. In addition, approximately $45 million of the increase in operating expense was due to the mandatory pharmaceutical manufacturers fee associated with U.S. health care reform.

In the third quarter of 2011, the company recognized a charge of $25.2 million for restructuring primarily related to severance costs from previously announced strategic actions that the company is taking to reduce its cost structure and global workforce. In the third quarter of 2010, the company recognized restructuring charges of $59.5 million, primarily related to the previously announced strategic actions.

Operating income in the third quarter of 2011 was $1.586 billion, a decrease of 6 percent compared to the third quarter of 2010, due primarily to lower gross margin percent and increased marketing, selling and administrative expenses.

Other income (expense) was a net expense of $83.4 million, compared to net expense of $21.7 million in the third quarter of 2010. The increase in third quarter 2011 expense was driven primarily by the partial impairment of an acquired in-process research and develo
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Lilly Declares Fourth-Quarter 2011 Dividend
2. Lilly Announces Changes in Senior Management
3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
7. Lilly Health Channel Debuts on YouTube
8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)...  EnteroMedics Inc. (NASDAQ: ETRM ), a developer ... treat obesity, metabolic diseases, and other gastrointestinal disorders, announced ... 40,229,886 units. Each unit consists of one share of ... purchase one share of common stock, and 0.50 of ... common stock, at a purchase price of $0.87 per ...
(Date:6/30/2015)... Calif. and COPENHAGEN, Denmark ... Inc. , a global leader in clinical and commercial ... today that, as part of its global manufacturing capacity ... North American manufacturing facility in Bothell, Washington ... 6Pack™ facility.  The Bioreactor 6Pack™ configuration consists of six ...
(Date:6/29/2015)... Mordor Intelligence presents their Global Pharmaceutical Packaging Market ... Metal) - ByType of Packaging (Ampules, Blister Packs, Bottles, Canisters, ... By Geographical Region ( North America , ... Latin America , Middle East ... Industry Value Chain Analysis, Porter,s 5 Force Analysis, Drivers, Restraints, ...
Breaking Medicine Technology:EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3CMC Biologics Expands GMP Manufacturing Capacity in the United States 2CMC Biologics Expands GMP Manufacturing Capacity in the United States 3Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 2Global Pharmaceutical Packaging Market - North America and Europe Expected to Lead Followed by the Asia Pacific Market 3
... Cepheid (Nasdaq: CPHD ) today announced that ... Vice President of Infectious Disease Research and Development, reporting ... offers an impressive menu of eleven highly regarded Xpert® ... aggressively to extend our leadership with next-generation products, including ...
... 2011 In a recent announcement by Neurelis, ... positive clinical results in a Phase I pharmacokinetic ... at Particle Sciences.  In the Phase 1 clinical ... that reported in the literature for Diastat® (rectal ...
Cached Medicine Technology:Cepheid Appoints Vice President of Infectious Disease Research & Development 2Cepheid Appoints Vice President of Infectious Disease Research & Development 3Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam) 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... official ready-to-drink sponsor of two leading organizations dedicated to raising worldwide awareness of ... , I AM ADAPTIVE™ is now the official charity of FitAID. I AM ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood ... contest today. Why We Care Youth serves as a platform for young people living ... meant to them, and why U.S. policymakers should care about expanding access around the ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... device market research, has launched a new reimbursement insurance policy tracking and analysis ... to receive US insurance policy and rate updates in real-time from hundreds of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Tulika Ranjan, MD, a prominent ... (AHN) as Director of its Adult Neuro-Oncology program. , Dr. ... metastases, leptomeningeal disease and the neurological complications of cancer. She has special ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... national testosterone claims alleging heart attack and stroke incidents are linked to testosterone ... Day. The Case Management Conference is scheduled for July 9, 2015, according to ...
Breaking Medicine News(10 mins):Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:iData Research Introduces New Medical Insurance Reimbursement Policy & Rate Tracker Subscription Service 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 2Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 3Health News:Testosterone Lawsuit News: July Conference on Bellweather Trials 4
... ... proudly announces a new fund-raising campaign - the sale of ... living with HIV/AIDS and extreme poverty in Uganda. The money raised by ... and provide them with additional nutritional support. The MPWN "BONO" bracelets ...
... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, June ... in the development of alopecia areata, a disorder that ... genes are already associated with other autoimmune diseases, including ... may already be in the pipeline that could benefit ...
... ... stage a performance of the Radio City Rockettes in Vienna for the 2010 Life Ball on ... New York, NY ... performance of the Radio City Rockettes in Vienna for the 2010 Life Ball on July 17th, ...
... 2010 The Florida Biomedical Research Program has awarded ... from the Florida campus of The Scripps Research Institute. ... an associate professor in the Scripps Research Department of ... Bannister, assistant professor of medicinal chemistry and associate scientific ...
... the Stanford University School of Medicine have identified a ... because the existence of such a cell in the ... It may also explain why current immunotherapies are largely ... "These cells lack the traditional melanoma cell surface ...
... Dotinga HealthDay Reporter , WEDNESDAY, June 30 (HealthDay News) ... much later on in life, a new study suggests it might ... Canadian researchers believe they,ve found a link between exercise in adolescence ... The study doesn,t definitively prove that exercise lowers the risk of ...
Cached Medicine News:Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 2Health News:Mulago Positive Women's Network Announce Their "BONO" Bracelet Fundraiser to Benefit HIV+ Women in Uganda 3Health News:Genes Tied to Hair Loss Disorder 2Health News:Genes Tied to Hair Loss Disorder 3Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 2Health News:DVF To Bring The Radio City Rockettes To Vienna's Life Ball 3Health News:Scripps Research scientists share $2 million in Florida state research grants 2Health News:Melanoma-initiating cell identified by Stanford scientists 2Health News:Melanoma-initiating cell identified by Stanford scientists 3Health News:Melanoma-initiating cell identified by Stanford scientists 4Health News:Exercise May Guard Girls Against Dementia in Senior Years 2
... The table-mounted hip ... hands-free exposure for total ... to accommodate individual surgeon ... of any size. Hand-held ...
... gelatinase-associated lipocalin, lipocalin-2) is a new early ... renal failure with a >90% positive predictive ... urine, as early as 2 hours after ... diagnostic marker for acute renal failure. ,Quantitative ...
... "Beautiful tissue is how one neurosurgeon describes ... Needle. By "beautiful he means a,cleaner cut ... are,functions of the needles optimized vacuum and ... captive locking thumb nut holds vacuum,in the ...
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
Medicine Products: